Henry Schein Inc (HSIC)
73.77
+0.04
(+0.05%)
USD |
NASDAQ |
Nov 21, 16:00
72.61
-1.16
(-1.57%)
After-Hours: 07:55
Henry Schein Revenue (Quarterly): 3.174B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 3.174B |
June 30, 2024 | 3.136B |
March 31, 2024 | 3.172B |
December 31, 2023 | 3.017B |
September 30, 2023 | 3.162B |
June 30, 2023 | 3.10B |
March 31, 2023 | 3.06B |
December 31, 2022 | 3.371B |
September 30, 2022 | 3.067B |
June 30, 2022 | 3.03B |
March 31, 2022 | 3.179B |
December 31, 2021 | 3.331B |
September 30, 2021 | 3.178B |
June 30, 2021 | 2.967B |
March 31, 2021 | 2.925B |
December 31, 2020 | 3.166B |
September 30, 2020 | 2.840B |
June 30, 2020 | 1.684B |
March 31, 2020 | 2.429B |
December 31, 2019 | 2.669B |
September 30, 2019 | 2.509B |
June 30, 2019 | 2.448B |
March 31, 2019 | 2.360B |
December 31, 2018 | 2.473B |
September 30, 2018 | 2.356B |
Date | Value |
---|---|
June 30, 2018 | 2.316B |
March 31, 2018 | 2.273B |
December 31, 2017 | -260.05M |
September 30, 2017 | 3.161B |
June 30, 2017 | 3.059B |
March 31, 2017 | 2.923B |
December 31, 2016 | 3.121B |
September 30, 2016 | 2.865B |
June 30, 2016 | 2.873B |
March 31, 2016 | 2.713B |
December 31, 2015 | 2.851B |
September 30, 2015 | 2.686B |
June 30, 2015 | 2.629B |
March 31, 2015 | 2.464B |
December 31, 2014 | 2.702B |
September 30, 2014 | 2.624B |
June 30, 2014 | 2.615B |
March 31, 2014 | 2.430B |
December 31, 2013 | 2.526B |
September 30, 2013 | 2.349B |
June 30, 2013 | 2.392B |
March 31, 2013 | 2.294B |
December 31, 2012 | 2.408B |
September 30, 2012 | 2.231B |
June 30, 2012 | 2.201B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.684B
Minimum
Jun 2020
3.371B
Maximum
Dec 2022
2.983B
Average
3.084B
Median
Revenue (Quarterly) Benchmarks
Standard BioTools Inc | 44.97M |
Ainos Inc | -- |
Zomedica Corp | 6.997M |
LENSAR Inc | 13.54M |
Intelligent Bio Solutions Inc | 0.8723M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 99.00M |
Total Expenses (Quarterly) | 2.969B |
EPS Diluted (Quarterly) | 0.78 |
Enterprise Value | 13.19B |
Gross Profit Margin (Quarterly) | 31.29% |
Profit Margin (Quarterly) | 3.12% |
Earnings Yield | 3.31% |
Operating Earnings Yield | 6.29% |
Normalized Earnings Yield | 4.092 |